The latest price target for SI-BONE (NASDAQ:SIBN) was reported by Morgan Stanley on August 6, 2024. The analyst firm set a price target for $19.00 expecting SIBN to rise to within 12 months (a possible 21.17% upside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for SI-BONE (NASDAQ:SIBN) was provided by Morgan Stanley, and SI-BONE maintained their overweight rating.

There is no last upgrade for SI-BONE

There is no last downgrade for SI-BONE.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SI-BONE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SI-BONE was filed on August 6, 2024 so you should expect the next rating to be made available sometime around August 6, 2025.

While ratings are subjective and will change, the latest SI-BONE (SIBN) rating was a maintained with a price target of $21.00 to $19.00. The current price SI-BONE (SIBN) is trading at is $15.68, which is out of the analyst’s predicted range.